OBJECTIVES: To test the hypothesis that high bone mass density (BMD), a potential marker for cumulative exposure to endogenous estrogen, calcium and vitamin D intake, is associated with a lower risk of colon cancer, and that women with a lower BMD are likely to develop a more aggressive form of colon cancer, as defined by mortality. STUDY DESIGN AND SETTING: BMD was measured in three different sites (Ward's triangle, trochanter, femoral neck) in 1,471 women 60 years of age. All incident cases of colon cancers were identified through record-linkage of cancer registry. The women were followed for a mean of 9.5 years. RESULTS: Overall 31 cases of colon cancer were observed among 28.6 expected (standardized incidence ratio (SIR) = 1.09, 95% confidence interval: 0.79-1.25). The SIR decreased with increasing BMD showing a significantly decreasing risk of 20% for women who were at the higher BMD comparatively to women who were at the lower BMD in all the skeletal sites. The 10-year survival rates showed that survival was increasing with increased BMD, but not significantly. CONCLUSION: The findings suggest that postmenopausal women with lower BMD have an increased risk of colon cancer. The biological mechanisms linking bone mass to colon cancer risk are not clear.
OBJECTIVES: To test the hypothesis that high bone mass density (BMD), a potential marker for cumulative exposure to endogenous estrogen, calcium and vitamin D intake, is associated with a lower risk of colon cancer, and that women with a lower BMD are likely to develop a more aggressive form of colon cancer, as defined by mortality. STUDY DESIGN AND SETTING: BMD was measured in three different sites (Ward's triangle, trochanter, femoral neck) in 1,471 women 60 years of age. All incident cases of colon cancers were identified through record-linkage of cancer registry. The women were followed for a mean of 9.5 years. RESULTS: Overall 31 cases of colon cancer were observed among 28.6 expected (standardized incidence ratio (SIR) = 1.09, 95% confidence interval: 0.79-1.25). The SIR decreased with increasing BMD showing a significantly decreasing risk of 20% for women who were at the higher BMD comparatively to women who were at the lower BMD in all the skeletal sites. The 10-year survival rates showed that survival was increasing with increased BMD, but not significantly. CONCLUSION: The findings suggest that postmenopausal women with lower BMD have an increased risk of colon cancer. The biological mechanisms linking bone mass to colon cancer risk are not clear.
Authors: Y Zhang; D T Felson; R C Ellison; B E Kreger; A Schatzkin; J F Dorgan; L A Cupples; D Levy; D P Kiel Journal: Am J Epidemiol Date: 2001-01-01 Impact factor: 4.897
Authors: Jennifer Lin; Shumin M Zhang; Nancy R Cook; Joann E Manson; Julie E Buring; I-Min Lee Journal: Am J Epidemiol Date: 2007-01-10 Impact factor: 4.897
Authors: Jennifer Lin; Shumin M Zhang; Nancy R Cook; JoAnn E Manson; I-Min Lee; Julie E Buring Journal: Am J Epidemiol Date: 2005-04-15 Impact factor: 4.897
Authors: Eunyoung Cho; Stephanie A Smith-Warner; Donna Spiegelman; W Lawrence Beeson; Piet A van den Brandt; Graham A Colditz; Aaron R Folsom; Gary E Fraser; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Anthony B Miller; Pirjo Pietinen; John D Potter; Thomas E Rohan; Paul Terry; Paolo Toniolo; Mikko J Virtanen; Walter C Willett; Alicja Wolk; Kana Wu; Shiaw-Shyuan Yaun; Anne Zeleniuch-Jacquotte; David J Hunter Journal: J Natl Cancer Inst Date: 2004-07-07 Impact factor: 13.506
Authors: Joan M Lappe; Dianne Travers-Gustafson; K Michael Davies; Robert R Recker; Robert P Heaney Journal: Am J Clin Nutr Date: 2007-06 Impact factor: 7.045
Authors: Kana Wu; Diane Feskanich; Charles S Fuchs; Walter C Willett; Bruce W Hollis; Edward L Giovannucci Journal: J Natl Cancer Inst Date: 2007-07-10 Impact factor: 13.506
Authors: Chris R Cardwell; Christian C Abnet; Philip Veal; Carmel M Hughes; Marie M Cantwell; Liam J Murray Journal: Int J Cancer Date: 2012-01-11 Impact factor: 7.396
Authors: Nora L Nock; Aimee Patrick-Melin; Marc Cook; Cheryl Thompson; John P Kirwan; Li Li Journal: Int J Cancer Date: 2010-12-08 Impact factor: 7.396
Authors: Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman Journal: Eur J Epidemiol Date: 2009 Impact factor: 8.082